AL
EQIX icon

Aspiriant LLC’s Equinix EQIX Stock Holding History

Aspiriant LLC’s Portfolio EQIX Stock Details EQIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Buy
+558
New +$597K 0.01% 223

Other funds holding EQIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aspiriant LLC's EQIX Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Equinix (EQIX) in Q2 2026: 558 shares worth $582K. The stake represents 0.01% of the portfolio and ranks #223 among its holdings.

1,356 funds tracked by Wall St. Rank hold EQIX as of Q2 2026.

  • Aspiriant LLC held 558 shares of Equinix worth $582K as of Q2 2026.
  • Equinix was a new Aspiriant LLC position in Q2 2026.
  • Equinix made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #223 holding.
  • 1,356 funds tracked by Wall St. Rank held Equinix as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.